Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
医学
2型糖尿病
肥胖
内科学
糖尿病
受体
内分泌学
相（物质）
临床试验
梅德林
临床研究阶段
作者
Deborah B Horn,Donna H. Ryan,Sanja Giljanovic Kis,Breno Alves,Yi-Ming Mu,Sin Gon Kim,Jens Aberle,Stephen C. Bain,SHERYL ALLEN,Elizabeth Bianca Sarker,Qiwei Wu,Adam Stefanski,Irina Jouravskaya,Deborah B Horn,Donna H. Ryan,Sanja Giljanovic Kis,Breno Alves,Yi-Ming Mu,Sin Gon Kim,Jens Aberle
PDF的下载单位、IP信息已删除
(2025-6-4)
潇洒的惋清
Copyright
GingerF
学术文献互助
不潮薯饼
Oyama
无极微光
Zephyrite
More
Kao
诚心香菇
cdercder
动听白风
BigTong
孤独的甜瓜
初遇之时最暖
Criminology34
wangj189
jinli
arniu2008
皖公网安备34019202002308
